Status:
COMPLETED
Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Stryker Canada LP
Conditions:
Total Hip Replacement
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Primary total hip arthroplasty (THA) has been a very successful surgical intervention in the geriatric population. Numerous studies have reported good mid and long term results of THA in patients over...
Eligibility Criteria
Inclusion
- Males or females scheduled for primary THA to treat non-inflammatory arthritis
- Less than 61 years old at time of surgery
- Able to speak and read the English language or have an available translator
- Dorr Index A or B bone quality on preoperative radiographs
- Willing and able to return for follow-up visits
Exclusion
- Have femoral or acetabular bone deficiency requiring augmentation
- Ongoing corticosteroid use
- Dorr Index C bone quality on the preoperative radiograph
- Required a prosthesis neck length of greater than five millimeters
Key Trial Info
Start Date :
November 1 1997
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT01522014
Start Date
November 1 1997
End Date
June 1 2009
Last Update
July 28 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2B7
2
Royal Alexandra Hospital
Edmonton, Alberta, Canada